Form 8-K - Current report:
SEC Accession No. 0001564590-21-045220
Filing Date
2021-08-20
Accepted
2021-08-19 19:45:42
Documents
16
Period of Report
2021-08-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20210819.htm   iXBRL 8-K 37474
2 EX-99.1 fgen-ex991_35.htm EX-99.1 42099
3 GRAPHIC g0r02nlhhqpu000003.jpg GRAPHIC 11792
4 GRAPHIC g0r02nlhhqpu000002.jpg GRAPHIC 4966
5 GRAPHIC g0r02nlhhqpu000001.jpg GRAPHIC 7377
  Complete submission text file 0001564590-21-045220.txt   249218

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA fgen-20210819.xsd EX-101.SCH 5685
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20210819_lab.xml EX-101.LAB 18595
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20210819_pre.xml EX-101.PRE 11035
9 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20210819_htm.xml XML 3400
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 211191418
SIC: 2834 Pharmaceutical Preparations